December 6, 2007
GTC Appoints Gray To Board
By Matthew L. Brown
GTC Biotherapeutics Inc. announced that Mary Ann Gray, president of New York-based Gray Strategic Advisors LLC, has been elected to its board of directors.
GTC’s board now has a total of eleven directors.
Gray Strategic Advisors is a strategic planning and advisory firm for biotechnology companies.
Gray is also a board member at Telik Inc., Dyax Corp., and Acadia Pharmaceuticals. Gray has also been a senior biotechnology analyst at Raymond James & Associates, Warburg Dillon Read and Kidder Peabody & Co. Gray served as a senior scientist at Schering-Plough Research and NeoRx Corp.
GTC’s board now has a total of eleven directors.
Gray Strategic Advisors is a strategic planning and advisory firm for biotechnology companies.
Gray is also a board member at Telik Inc., Dyax Corp., and Acadia Pharmaceuticals. Gray has also been a senior biotechnology analyst at Raymond James & Associates, Warburg Dillon Read and Kidder Peabody & Co. Gray served as a senior scientist at Schering-Plough Research and NeoRx Corp.
WBJ Web Partners
Most Recent
Most Recent
0 Comments